Celecoxib in the treatment of primary dysmenorrhea: Results from two randomized, double-blind, active- and placebo-controlled, crossover studies

Stephen Daniels, Jeffery Robbins, Christine R. West, Mary Anne Nemeth
In: Clinical Therapeutics · 2009 · vol. 31(6) , pp. 1192–1208 · doi:10.1016/j.clinthera.2009.06.003 · PMID:19695387 · W2035477546
article OA: closed CC0 ⤵ 7 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Two randomized, double-blind, placebo-controlled crossover studies investigated celecoxib's efficacy in treating primary dysmenorrhea, comparing it against active and placebo treatments.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

dysmenorrhea

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (58)

Cited by (7)

Source provenance

openalex
last seen: 2026-05-11T05:51:57.177246+00:00
unpaywall
last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0 · commercial use OK